Explore this research category across breast cancer datasets
| RNA Name | Mechanism of Action | Effect on Cancer | Cancer Type | Reference |
|---|---|---|---|---|
|
miR-203a-3p
miRNA |
Target of cuproptosis-related genes (CRGs) | Potential therapeutic target for TNBC | Breast Cancer |
PubMed
Reference PMID: 38601669 |
|
miR-370-3p
miRNA |
Targets DLD mRNA | Associated with endocrine therapy resistance in ER+ breast cancer | Breast Cancer |
PubMed
Reference PMID: 37143115 |
|
miR-432-5p
miRNA |
Targets DLD mRNA | Associated with endocrine therapy resistance in ER+ breast cancer | Breast Cancer |
PubMed
Reference PMID: 37143115 |
|
miR-192-5p
miRNA |
Part of the PRNP/miRNA hsa-miR-192-5p and hsa-miR-215-5p/lncRNA CARMN ceRNA network | Implicated in cuproptosis regulation | Breast Cancer |
PubMed
Reference PMID: 36980514 |
|
miR-215-5p
miRNA |
Part of the PRNP/miRNA hsa-miR-192-5p and hsa-miR-215-5p/lncRNA CARMN ceRNA network | Implicated in cuproptosis regulation | Breast Cancer |
PubMed
Reference PMID: 36980514 |
|
miR-92b-3p
miRNA |
Regulates MTF1 in the XIST/miR-92b-3p/MTF1 axis | Poor prognosis with low MTF1 expression | Breast Cancer |
PubMed
Reference PMID: 36312586 |
|
miR-335
miRNA |
Triggers oxidative stress-mediated pyroptosis by targeting ZNF-148/SOD2 signaling cascade | Suppresses breast cancer progression | Breast Cancer |
PubMed
Reference PMID: 37909239 |
|
miR-200b
miRNA |
Regulates pyroptosis via JAZF1/NF-κB axis | Inhibits tumorigenesis of breast cancer | Breast Cancer |
PubMed
Reference PMID: 33728753 |
|
miR-1290
miRNA |
Modulates NLRP3-mediated pyroptosis | Increases radioresistance in triple-negative breast cancer | Breast Cancer |
PubMed
Reference PMID: 35471684 |
|
miR-182
miRNA |
Inhibits NLRP3 to suppress pyroptosis | Enhances chemoresistance of breast cancer | Breast Cancer |
PubMed
Reference PMID: 36905318 |